2022
DOI: 10.21037/atm-22-555
|View full text |Cite
|
Sign up to set email alerts
|

Bromodomain containing 4 transcriptionally activated Deltex E3 ubiquitin ligase 2 contributes to glioma progression and predicts an unfavorable prognosis

Abstract: Background: Glioblastoma multiforme (GBM) is the most common type of glioma, and the most aggressive brain malignancy in adults. This study sought to identify novel survival-status related markers, and examine their function in glioma. Methods:The gene expression, survival heatmaps, and Kaplan-Meier survival plots of the genes were analyzed by using gene expression profiling interactive analysis (GEPIA) dataset, Linked Omics. The singlecell data analysis and tumor immune infiltration analysis was conducted by … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(4 citation statements)
references
References 48 publications
0
4
0
Order By: Relevance
“…The characteristics of members of this family include a conserved C terminus consisting of a RING and DTC domain [ 11 ]. DTX2 has been reported to be involved in many human cancers with functions as an oncogene and can be used as a prognostic marker [ 5 , 8 ]. In this study, we showed that the high expression of DTX2 in glioma tissues was associated with poor patient prognosis.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…The characteristics of members of this family include a conserved C terminus consisting of a RING and DTC domain [ 11 ]. DTX2 has been reported to be involved in many human cancers with functions as an oncogene and can be used as a prognostic marker [ 5 , 8 ]. In this study, we showed that the high expression of DTX2 in glioma tissues was associated with poor patient prognosis.…”
Section: Discussionmentioning
confidence: 99%
“…proposed DTX2 as part of an 18-gene panel of prognostic biomarkers whose expression is related to poor outcomes in metastatic breast cancer [ 7 ]. BRD4 transcriptionally activates DTX2, contributing to glioma progression, and predicts an unfavorable prognosis [ 8 ]. However, studies of DTX2 in cancer have been limited, with very few reports on its role in glioma.…”
Section: Instructionsmentioning
confidence: 99%
See 1 more Smart Citation
“…By the same token, another study in colon cancer cells (SW620, LoVo) [ 44 ] showed DTX2 to promote migration/invasion, increase NOTCH2 levels and trigger AKT activation. Poor survival correlation with DTX2 was observed also in Glioblastoma multiforme along with the demonstration that DTX2 silencing in glioma cell lines (DBTRG, U251) inhibited both their growth and migration abilities [ 45 ]. The same study found DTX2 transcriptional activation to depend on BRD4 binding to the DTX2 promoter.…”
Section: Dtx Proteins Signaling In Mammalian and Cancer Cells: A Phos...mentioning
confidence: 99%